Unsurprisingly, mHealth was a hotly debated topic during the 2015 eHealth Week hosted by the Latvian Council Presidency. In addition to the official conference programme, where the mHealth summit uncovered some of the latest developments in this area, the European Commission also organised a stakeholder meeting including industry and civil society representatives to determine the appropriate level of regulation for mHealth at EU level.
European Health Commissioner Vytenis Andriukaitis opened the 2015 eHealth Week in Riga, pointing out eHealth’s contribution to the areas of prevention and health risk management, which in turn can facilitate the maintenance of sustainable health systems. He said that eHealth was generating jobs and growth on the one hand, and offering innovative solutions to healthy people, patients and health professionals on the other, citing electronic health records, remote patient consultations and ePrescription as examples. He also noted that telemedicine and telecare could become tools for better healthcare access across and within borders.
Regarding mHealth, Commissioner Andriukaitis felt that apps have many beneficial uses which range from, inter alia, information provision to enabling individuals to engage in their own health management, tracking fitness levels and monitoring health status. He reaffirmed his goal to raise the profile of prevention as a necessary prerequisite for e/mHealth to blossom, and he stated that regulatory challenges (e.g. related to quality, safety and confidentiality, but also interoperability) needed to be overcome. The assessment of national health systems should include the implementation of eHealth as this is also important for moving towards integrated care and preventing and managing chronic diseases.
His announcement of a new Joint Action on eHealth to follow up on the work of the eHealth Governance Initiative – which would provide technical and scientific support to the eHealth Network – triggered a joint letter by leading health stakeholders, including EPHA members the Pharmaceutical Group of the European Union (PGEU) and the European Federation of Nurses’ Associations (EFN), expressing concern about participation. The letter is also supported by EPHA, especially given that the former eHealth Stakeholder Group is no longer operational, and its members were neither consulted nor invited to join the Joint Action on eHealth.
The involvement of, and endorsement by, health professionals, patients and representatives of vulnerable groups is vital when it comes to legitimising eHealth in Europe. Moreover, further discussions about the eInclusion potential of e- and mHealth solutions in Europe – which were notably absent during 2015 eHealth Week – depend on their input. Unfortunately, the ‘health’ element all too often plays second fiddle to dominant discourses about employment, technological innovation and global competitiveness.
On a positive note, two new consultative mHealth working groups, one to review an ‘Industry Code of Practice’, the other on ‘Quality, Safety and Standards’, have been set up by DG CONNECT. Furthermore, civil society and industry views on the merits of soft versus hard legislation were sought in Riga following the analysis of responses to the Green Paper consultation on mHealth which the Commission also published in early 2015. The question is whether the concerns and needs of end users will be heard and taken into account when it comes to developing future policy.
—-
Related articles:
-[->5568]
-[->6105]
-[->6141]
